Plasma-lyte 148: Clinical Trials

5 trials of Plasma-lyte 148, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5

Follow Plasma-lyte 148: new trials by email Literature Review of Plasma-lyte 148 trials Research Report on Plasma-lyte 148

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
Plasma-Lyte 148, 0.9% sodium chloride - Diabetic Ketoacidosis
Phase 3CompletedThe George Institute5472024-03-142026-10-05
Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure
Norepinephrine, Lactated Ringers, Intravenous, normal saline - Respiratory Failure, Hypotension and Shock
Phase 3CompletedWright State University422022-08-092024-07-15
Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis
Lactated Ringer, Normal Saline, Plasma-lyte - Shock, Septic
Phase 3CompletedChildren's Hospital of Philadelphia90412020-08-252026-03-05
Better Evidence for Selecting Transplant Fluids
Plasma-Lyte 148 (approx. pH 7.4) IV Infusion, 0.9% SODIUM CHLORIDE 9g/L injection BP - End Stage Kidney Disease, Delayed Graft Function
Phase 3CompletedThe University of Queensland8082018-01-262024-10-15
Balanced Solution Versus Saline in Intensive Care Study
Plasma-Lyte, Saline 0.9%, Slow infusion speed - Critical Illness, Acute Kidney Injury
Phase 3CompletedHospital do Coracao110752017-05-272021-04-19

Conditions studied

Shock (2)  ·  Acute Kidney Injury (1)  ·  Critical Illness (1)  ·  Delayed Graft Function (1)  ·  Diabetic Ketoacidosis (1)  ·  Hypotension (1)  ·  Kidney Failure, Chronic (1)  ·  Respiratory Insufficiency (1)  ·  Sepsis (1)  ·  Shock, Septic (1)

Sponsors

Children's Hospital of Philadelphia (1)  ·  Hospital do Coracao (1)  ·  The George Institute (1)  ·  The University of Queensland (1)  ·  Wright State University (1)

Countries

Australia (2)  ·  United States (2)  ·  Brazil (1)  ·  New Zealand (1)

Top investigators

Alexandre B Cavalcanti, MD, PhD (1)  ·  Fernando G Zampieri, MD (1)  ·  Fran Balamuth, MD PhD MSCE (1)  ·  Matthew Koroscil, MD (1)  ·  Michael Collins, MBChB,FRACP,PhD (1)  ·  Nilton Brandao, MD, PhD (1)  ·  Rodrigo S Biondi, MD (1)  ·  Steven Chadban, BMed(hons),FRACP,PhD (1)  ·  Yonatan Dollin, DO (1)

Results publications

PMID 28651514, PMID 32450917, PMID 34375394, PMID 34547081, PMID 34742327, PMID 35042554, PMID 35349397, PMID 35843046, PMID 36735931, PMID 36888820, PMID 37343576, PMID 42028918

NIH funding

R01HD101528 (1)